Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension

Clinical trial NCT04114539 · COMPLETED

Trial details

NCT number: NCT04114539
Sponsor: Emalex Biosciences Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tourette Syndrome in Children Tourette Syndrome in Adolescence

Start date: 2019-10-04
Primary completion: 2022-11-11
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.